Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a 20.916\% human ether-à-go-go related gene (hERG) inhibition at a concentration of 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a COC(=O)c1ccc(/C=C2/SC(=S)N(CCC(=O)N3CCOCC3)C2=O)cc1
b COc1ccc(CCNC(=O)C(=O)NCC2OCCN2S(=O)(=O)c2cc(F)ccc2F)cc1OC
c NS(=O)(=O)c1ccc(CNC(=O)Cc2cccs2)cc1
Answer: a. COC(=O)c1ccc(/C=C2/SC(=S)N(CCC(=O)N3CCOCC3)C2=O)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COC(=O)c1ccc(/C=C2/SC(=S)N(CCC(=O)N3CCOCC3)C2=O)cc1
COC(=O)c1ccc(/C=C2/SC(=S)N(CCC(=O)N3CCOCC3)C2=O)cc1
methyl 4-[(E)-[3-(3-morpholin-4-yl-3-oxopropyl)-4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene]methyl]benzoate